CD69: from activation marker to metabolic gatekeeper-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD69: from activation marker to metabolic gatekeeper

Published:2017-06 Issue:6 Volume:47 Page:946-953
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Cibrián Danay¹²³,Sánchez-Madrid Francisco¹²³^ORCID

Affiliation:

1. Hospital Universitario de la Princesa; Instituto Investigación Sanitaria Princesa (IIS-IP); Universidad Autónoma de Madrid; Madrid Spain

2. Centro Nacional Investigaciones Cardiovasculares (CNIC); Madrid Spain

3. CIBER de Enfermedades Cardiovasculares; Instituto de Salud Carlos III; Madrid Spain

Funder

Spanish Ministry of Economy and Competitiveness

Comunidad de Madrid

CIBER de Enfermedades Cardiovasculares

Instituto de Salud Carlos III

BIOIMID

Fundación La Marató TV3

Federación Española de Enfermedades Raras

Ministry of Economy, Industry and Competitiveness

Pro-CNIC Foundation

Severo Ochoa Center of Excellence

European Research Council

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/eji.201646837/fullpdf

Reference63 articles.

1. Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigens;Ziegler;Eur. J. Immunol.,1993

2. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors;Lopez-Cabrera;J. Exp. Med.,1993

3. Transcriptional regulation of the gene encoding the human C-type lectin leukocyte receptor AIM/CD69 and functional characterization of its tumor necrosis factor-alpha-responsive elements;Lopez-Cabrera;J. Biol. Chem.,1995

4. Expression of the leukocyte early activation antigen CD69 is regulated by the transcription factor AP-1;Castellanos;J. Immunol.,1997

5. Is CD69 an effective brake to control inflammatory diseases?;Gonzalez-Amaro;Trends Mol. Med.,2013

Cited by 609 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amelioration of immunoglobulin A vasculitis by suppression of the pathological expansion of T follicular helper 17 cells;Journal of Autoimmunity;2024-12

2. Prophylactic and therapeutic cancer vaccine with continuous localized immunomodulation;Nanomedicine: Nanotechnology, Biology and Medicine;2024-11

3. Transdermal microneedles integrating biomimetic self-adjuvant particles for enhanced immunity;Nano Today;2024-10

4. Enhanced T cell activation and cytotoxicity against AML via targeted anti-CD99 nanoparticle treatment;Biomedicine & Pharmacotherapy;2024-10

5. The Influence of Metabolites of Microorganisms of the Genus Bacillus from Permafrost Rocks on T Lymphocyte Differentiation;Bulletin of Experimental Biology and Medicine;2024-09-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3